Compare RDW & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDW | BHVN |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 2017 |
| Metric | RDW | BHVN |
|---|---|---|
| Price | $7.89 | $11.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | $12.67 | ★ $30.36 |
| AVG Volume (30 Days) | ★ 35.4M | 2.6M |
| Earning Date | 03-09-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $296,147,000.00 | N/A |
| Revenue This Year | $9.16 | N/A |
| Revenue Next Year | $40.24 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.87 | $7.48 |
| 52 Week High | $26.66 | $44.28 |
| Indicator | RDW | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 48.00 |
| Support Level | $8.65 | $11.35 |
| Resistance Level | $10.40 | $13.08 |
| Average True Range (ATR) | 1.36 | 0.78 |
| MACD | -0.51 | -0.09 |
| Stochastic Oscillator | 1.26 | 33.15 |
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.